Adage Capital Partners’s Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 NUVB.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72K | Hold |
266,666
| – | – | ﹤0.01% | 835 |
|
|
2025
Q1 | $85.3K | Hold |
266,666
| – | – | ﹤0.01% | 824 |
|
|
2024
Q4 | $61.3K | Hold |
266,666
| – | – | ﹤0.01% | 859 |
|
|
2024
Q3 | $26.1K | Hold |
266,666
| – | – | ﹤0.01% | 838 |
|
|
2024
Q2 | $42.7K | Hold |
266,666
| – | – | ﹤0.01% | 832 |
|
|
2024
Q1 | $80.7K | Hold |
266,666
| – | – | ﹤0.01% | 829 |
|
|
2023
Q4 | $16K | Hold |
266,666
| – | – | ﹤0.01% | 827 |
|
|
2023
Q3 | $26.7K | Hold |
266,666
| – | – | ﹤0.01% | 843 |
|
|
2023
Q2 | $44.1K | Hold |
266,666
| – | – | ﹤0.01% | 831 |
|
|
2023
Q1 | $32K | Hold |
266,666
| – | – | ﹤0.01% | 893 |
|
|
2022
Q4 | $38.5K | Hold |
266,666
| – | – | ﹤0.01% | 919 |
|
|
2022
Q3 | $53K | Hold |
266,666
| – | – | ﹤0.01% | 987 |
|
|
2022
Q2 | $75K | Hold |
266,666
| – | – | ﹤0.01% | 1015 |
|
|
2022
Q1 | $215K | Hold |
266,666
| – | – | ﹤0.01% | 999 |
|
|
2021
Q4 | $504K | Hold |
266,666
| – | – | ﹤0.01% | 929 |
|
|
2021
Q3 | $683K | Hold |
266,666
| – | – | ﹤0.01% | 927 |
|
|
2021
Q2 | $693K | Hold |
266,666
| – | – | ﹤0.01% | 922 |
|
|
2021
Q1 | $712K | Buy |
+266,666
| New | +$712K | ﹤0.01% | 899 |
|